PARP Inhibitors: a Breakthrough in Cancer Therapy?

Stanford Cancer Institute Breakthroughs in Cancer: Ursula Matulonis, MDПодробнее

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer InstituteПодробнее

What have been the biggest breakthroughs in ovarian cancer treatment in the last 20 years?Подробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Ovarian Cancer: PARP Inhibitors and Beyond (Webinar) May 8th World Ovarian Cancer DayПодробнее

Medical Breakthroughs from ASCOПодробнее

PARP Inhibitors Advance Beyond Treatment of BRCA1/2-Mutant Gynecologic CancersПодробнее

Breast Cancer Breakthroughs: Inside The Latest Treatments | TODAYПодробнее

FDA Approvals in CSCC, NSCLC, and Myeloma, Breakthrough Designation in Prostate Cancer, and MoreПодробнее

PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSciПодробнее

The Role of Targeting DNA Repair with PARPПодробнее

Immunotherapy: The New Frontier of Cancer TherapyПодробнее

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope RugoПодробнее

PARP Inhibitors: a Breakthrough in Cancer Therapy?Подробнее

Potential Cancer BreakthroughПодробнее